Skip to main content

Reports

Search reports, investigative results, and agency plansShowing 1 - 10 of 155 results

Keyword

X
Treasury Inspector General for Tax Administration

Desk Review of the State of Alaska

The objective of this desk review is to evaluate the State of Alaska documentation supporting the uses of its Coronavirus Relief Fund proceeds as reported in GrantSolutions, and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period March 1 through December 31, 2020, as reported in cycles 1 through 3 in the GrantSolutions portal.
Department of Health & Human Services OIG

Awardee Challenges in Implementing COVID_19 Vaccination Program

CDC Immunization and Vaccines for Children Cooperative Agreement awardees, which are typically State and large metropolitan area public health departments, plan for and oversee the vaccine distribution and administration process. Stakeholders have acknowledged challenges early in Phase 1 distribution and dispensing, and note that these challenges will likely span all three phases identified in the CDC's COVID-19 Vaccine Playbook. We will interview all awardees to identify the reported challenges they are facing while distributing and dispensing vaccines. We will also ask awardees about effective strategies to mitigate those challenges, new challenges they anticipate, and how HHS can best support them in distributing and dispensing COVID-19 vaccines. In doing so, this review will provide HHS with timely and actionable information to address challenges associated with the COVID-19 vaccination efforts.
Department of Health & Human Services OIG

Audits of Medicare Part B Laboratory Services During the COVID-19 Pandemic

Our preliminary analysis has shown that the number of non-COVID-19 tests billed for Medicare Part B beneficiaries during the COVID-19 pandemic has decreased compared with the 6-month period before the pandemic, and many independent laboratories have encountered challenges in providing COVID-19 testing. We will conduct a series of audits on Medicare Part B laboratory services during the pandemic that will initially focus on the effect of the pandemic on non-COVID-19 testing. The series of audits will also focus on aberrant billing of COVID-19 testing during the pandemic.
Department of Homeland Security OIG

Audit of FEMA’s Controls over Mission Assignments in Response to COVID-19

The objective is to determine to what extent FEMA develops and oversees mission assignments for COVID-19 in accordance with FEMA’s policies and procedures.
Department of Health & Human Services OIG

Hospital Experiences Responding to the COVID-19 Pandemic: February 2021 Pulse Surveys

This study will serve as a followup to OIG's April 2020 report, Hospital Experiences Responding to the COVID-19 Pandemic: Results of a National Pulse Survey March 23—27, 2020 (OEI-06-20-00300), by surveying hospitals about their experiences in responding to COVID-19 approximately 1 year after the prior report. We will contact the same randomly selected hospitals and conduct pulse surveys to identify their current challenges in responding to COVID—19, anticipated challenges in returning to standard operations postpandemic, and how Government can best support hospitals. The review will provide timely information about hospital operations during the pandemic to HHS administrators and other decisionmakers.
Department of Health & Human Services OIG

Audit of HHS Sole Source Contracts Awarded for COVID-19 Testing

HHS established contracts under the Public Health and Social Services Emergency Fund to prevent, prepare for, and respond to the COVID-­19 pandemic. The contracts cover more than 600 COVID-19 testing sites in 48 states and the District of Columbia. The contracts utilize a Federal bundled payment program paid directly to retailers that receive a flat fee for each test administered, with participating retailers responsible for coordinating the full, end-to-end testing. The contracts that HHS awarded to contractors were sole source contracts totaling approximately $1 billion for COVID-19 testing. We will review the awarding and management of contracts for COVID-19 testing to determine compliance with applicable Federal statutes, regulations, HHS policies and procedures, contract terms and conditions, and the allowability of claimed costs.
Pandemic Response Accountability Committee

Multi-Dipping of Pandemic Response Funds Provided to Tribal Governments

The PRAC and pandemic OIGs identified the possibility of recipients receiving funding from multiple federal programs for the same purpose (multi-dipping) as a high risk area. This project will focus on funds received by tribal governments, and result in an information brief that identifies programs where multi-dipping has occurred in CARES Act programs allowing us to identify and scope the magnitude of the risk. 
Small Business Administration OIG

Inspection Notification: Small Business Administration's Implementation of the Economic Aid Act

The Office of Inspector General Audits Division will perform a review of the Small Business Administration’s implementation of the Economic Aid Act. The objective is to determine whether the Small Business Administration implemented the Paycheck Protection Program in accordance with the Economic Aid Act.
Department of Homeland Security OIG

DHS Prioritization of Frontline and Mission-Critical Employees for COVID-19 Vaccines

Evaluate how DHS determined employee status for placement into vaccine distribution priority groups and how, in conjunction with the Veterans Health Administration, DHS planned to triage and distribute available vaccine inventory and vaccinate frontline, mission-critical DHS staff Evaluate how DHS executed its plan.
Department of Health & Human Services OIG

Health Resources and Services Administration's Monitoring of High-Risk COVID-19 Grantees

The Health Resources and Services Administration (HRSA) is the primary Federal agency for improving health care to people who are geographically isolated and economically or medically vulnerable. HRSA should identify and mitigate risks related to awarding grants to health centers to minimize the potential misuse or loss of Federal funds. In spring 2020, HRSA awarded through three programs nearly $2 billion to approximately 1,380 health centers in response to the COVID-19 pandemic. To expedite distribution of this funding, HRSA did not require that health centers apply for grants. Instead, it made funds immediately available to health centers. Health centers had 30 days from the award release date to submit the information that is usually submitted, reviewed, and approved during the grant application process prior to a grantee receiving funding. We will determine whether HRSA had an effective process for identifying and monitoring high-risk health centers that received COVID-19 grants.